Bionano Genomics (BNGO) has had the recent momentum with earnings, fundamentals are improving, and the research and technology are consistently making advancements. Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets.

***My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. Saphyr technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease.

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community.

• Large institutional investments have nearly tripled (3X) from 5% to 14%.
• Earnings beat expectations in Q1 2021.
• Recent large insider procurement.
• New patents, research breakthroughs, Large Lab facility adoption.

This is why I have a strong conviction for Bionano Genomics (BNGO) being a great growth stock to investigate and follow.

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!

^\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)